BASEL, Switzerland,
May 18, 2021 /PRNewswire/
-- Ascensia Diabetes Care, a leading global diabetes care
company, has today announced that it has launched
GlucoContro.online, a browser based diabetes management and
analytics platform that enables data driven care for people using
one of the meters in the CONTOUR® blood glucose
monitoring portfolio. Through a single platform, people with
diabetes (PWDs) can access their diabetes data online and share it
with their healthcare providers (HCPs) and caregivers through
dedicated web Apps.
Using GlucoContro.online makes gathering, accessing and sharing
blood glucose data straightforward for PWDs. The easy-to-use and
intuitive cloud-based platform, opens directly in the browser and
provides a simple wizard for data download. For those using one of
the connected meters in the CONTOUR® portfolio it
gathers data directly from the CONTOUR®DIABETES app or
CONTOUR Cloud. It also provides the option for those not using a
connected meter to share their data via a cable, which requires a
simple single step installation, with no forced restart and the
appropriate devices are found automatically. Once the data has been
downloaded, the platform allows users to conveniently view data,
generate reports and share them across their care team.
For HCPs and caregivers, GlucoContro.online allows them to
easily view data, such as blood glucose measurements, insulin
dosing, food and activity by simply opening a user profile on the
platform, once the user has granted them permission.
In addition, the platform incorporates industry leading
innovations and other features that address some of the challenges
and concerns that HCPs and PWDs have experienced with existing
platforms. These include the ability to instantly onboard patients
through QR codes or a simple one-click invitation; the option for
PWDs to store data in their own personal cloud drive or offline
storage; and the ability to generate easy-to-read color coded
charts and reports to speed up and make it easier for HCPs to
analyze the data, alongside interactive aggregations or
groupings.
Rob Schumm, President at Ascensia
Diabetes Care commented: "Simplifying and improving the lives of
people living with diabetes through innovative solutions is at the
heart of all we do at Ascensia and the GlucoContro.online platform
is a step towards achieving that. It has been borne out of clearly
defined unmet needs from both healthcare professionals and people
with diabetes. From its simple installation through to the
functions that enable quick and easy access and analysis of data,
it provides a valuable and uncomplicated way to share and use blood
glucose and other data to help clinicians and people optimize their
diabetes management."
The platform, which has been piloted in Spain and KSA over the last six months, will
be available in Slovenia,
Italy, Poland, UK and Ireland by the end of Q2 and in Romania, Czech
Republic, Serbia, Portugal,
Bulgaria and Bosnia by the end of Q3, 2021. The long-term
goal is to offer GlucoContro.online in all the 58 markets where the
CONTOUR®DIABETES app is available for download, subject
to technical requirements being met.
GlucoContro.online is the outcome of a collaboration between
Ascensia and SdNcenter, a Polish-based company specialized in
delivering high-tech healthcare and integration solutions for
enterprise customers worldwide. Through this cooperation is has
been possible to build a platform which has the scalability to
handle data from over 150 million patients, 10,000 clinics and
100,000 HCPs. It has also been designed to be able to collect
additional data from other devices in the future, such as FitBit,
Apple Health, Google Health and Smart Scales.
Photo
- https://mma.prnewswire.com/media/1512231/Ascensia_GlucoContro_Infographic.jpg
Logo -
https://mma.prnewswire.com/media/749389/Ascensia_Diabetes_Care_Logo.jpg